secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2024-10-03T23:59:59+00:00
Accession:  0001683168-24-006896
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical appoints James B. Frakes as permanent CEO; COO Guy F. Cipriani departs
--------------------------------------------------------------------------------

- James B. Frakes, serving as interim CEO since Nov 7, 2023, appointed permanent CEO effective Oct 3, 2024; remains CFO and Board member.
- Guy F. Cipriani departed as COO effective Oct 3, 2024; departure not related to financial or reporting disagreements.
- Cipriani eligible for 12 months' severance and separation benefits subject to execution of release agreement.
- Company intends to enter amended employment agreement with Frakes for his CEO role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316824006896/0001683168-24-006896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316824006896/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-006896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer